Fig. 5From: Assessment of the follow-up interval changes of the less than 2 cm arterial phase enhancing hepatic nodules in correlation with Liver Imaging Reporting and Data System (LI-RADS) classification version 18 using contrast-enhanced multidetector computed tomographyCase 2: a 63-year-old male patient with cirrhosis. a MDCT in the arterial phase dated January 2017 reveals a small right hepatic lobe segment VI hyper-enhancing nodule measuring 8 mm showing no washout in the venous nor the delayed phases (not shown); this lesion is categorized as LIRADS-3. b MDCT in the arterial phase for the same patient 6 months later showing stationary size of the lesionBack to article page